Loading organizations...
§ Private Profile · Cambridge, MA, USA
Developing gene therapies to restore functional vision in patients.
Vedere Bio ll has raised $77.0M across 1 funding round.
Vedere Bio ll has raised $77.0M in total across 1 funding round.
Vedere Bio ll has raised $77.0M across 1 funding round. Most recently, it raised $77.0M Series A in May 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 18, 2021 | $77M Series A | Ting JIA (tj) | Atlas Venture, Casdin Capital, Benjamin Yerxa, Mission BioCapital, Samsara BioCapital | Announced |
Vedere Bio ll has raised $77.0M in total across 1 funding round.
Vedere Bio ll's investors include Ting Jia (TJ), Atlas Venture, Casdin Capital, Benjamin Yerxa, Mission BioCapital, Samsara BioCapital.